drugset / Trial / NCT00978302

Safety Study of Repeated, Escalating Doses of Intradermal Avotermin (Juvista)

NCT00978302

Phase 1 Completed 55 enrolled Renovo
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The purpose of this study is to determine the safety and local toleration and histological effects of various dose levels of avotermin (Juvista) injected intradermally in healthy male volunteers.

Timeline

Start
2001-05
Primary completion
2001-08
Completion
2001-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Avotermin Protein / enzyme biologic 50 ng Other
Subject Avotermin Protein / enzyme biologic 100 ng Other
Subject Avotermin Protein / enzyme biologic 500 ng Other
Subject Avotermin Protein / enzyme biologic 1000 ng Other
Subject Avotermin Protein / enzyme biologic 10 ug Other

Indications

No indication recorded.